Novo Nordisk's pricing procedures during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of selling price gouging, pointing out the stark contrast among U.S. prices and people in Europe and copyright.This led Novo Nordisk to carry out even further investigate into bigger dosages of semaglutide